Diabetes Care APC and Open Access: ADA's Clinical Powerhouse at Moderate Cost

Diabetes Care isn't just another diabetes journal. It's the most-cited journal in diabetes and endocrinology, with an impact factor around 14 (2024 JCR). It has held this position for decades, and its influence extends well beyond academic research into clinical practice.

The journal is best known for publishing:

• ADA Standards of Care: The annual ADA clinical practice guidelines are published in Diabetes Care every January. These guidelines are the primary reference for diabetes management worldwide, used by endocrinologists, primary care physicians, nurses, and pharmacists.
• Clinical trials: Major diabetes trial results regularly appear here, including studies on glucose management, cardiovascular outcomes, and technology interventions.
• Epidemiology: Large-scale population studies on diabetes prevalence, risk factors, and complications.
• Translational research: Studies that bridge basic diabetes biology and clinical application.
• Behavioral and lifestyle interventions: Research on diet, exercise, psychology, and self-management.
• Health services and delivery: Studies on care models, cost-effectiveness, and access to diabetes care.

Diabetes Care published approximately 400-500 articles in 2024. The desk-rejection rate is roughly 50-60%, and the overall acceptance rate is estimated at 15-20%. The editors prioritize clinical relevance and actionable findings. A well-designed clinical study with clear implications for diabetes management has a strong chance, even without a molecular mechanism.

Diabetes Care is hybrid:

1. Subscription track ($0 APC, page charges may apply): Published behind the ADA paywall. ADA members and institutional subscribers have access. No APC, but per-page charges may be invoiced depending on the article type.
2. Gold OA track ($3,000-$4,000): Immediate free access under a Creative Commons license. Page charges are typically waived or included.

The ADA's subscriber base is enormous. Over 16,000 ADA professional members have journal access, and most academic medical centers and hospital systems subscribe. Behind the paywall, your Diabetes Care paper reaches the diabetes care community effectively.

OA broadens the audience to community health workers, patients, health policy professionals, and researchers in low-resource settings. For papers with direct patient care implications, particularly on diabetes self-management or screening guidelines, OA can have measurable real-world impact.

The ADA's institutional deal landscape differs from large commercial publishers:

The ADA's publishing partnerships have evolved over the years. The association has worked with Silverchair and other platforms for journal hosting. Institutional agreements are less standardized than Springer Nature or OUP deals but are increasing as the transformative agreement model spreads.

For US diabetes researchers, the best approach is to check with your library about any ADA-specific publishing arrangements. Major diabetes research centers (Joslin Diabetes Center, Barbara Davis Center, etc.) may have institutional deals that cover or subsidize APCs.

The ADA provides financial support options:

• Geographic waivers: Authors from low-income and lower-middle-income countries can request full or partial APC waivers.
• Hardship waivers: Case-by-case consideration for authors demonstrating genuine financial need.
• ADA membership benefits: Members may receive reduced page charges and other fee reductions.
• ADA research grant holders: Researchers funded by ADA grants may receive preferential consideration for fee waivers, though this isn't guaranteed.

The ADA's identity as a patient-focused nonprofit means it takes accessibility seriously. The association doesn't want financial barriers to prevent good diabetes research from being published, particularly research from under-resourced settings where diabetes burden is growing fastest.

For NIDDK-funded and NIH-funded diabetes researchers, the green OA route is practical and free. Publish via the subscription track, deposit the accepted manuscript in PMC after 12 months. This satisfies federal public access requirements without any APC.

Diabetes Care supports both CC BY and CC BY-NC licenses. Plan S funders require CC BY. Select the correct license during the production stage.

Diabetes Care's annual publication of the ADA Standards of Care gives it unique influence in the field. These guidelines, published every January, are:

• The primary clinical reference for diabetes management in the United States
• Cited by insurance companies for treatment authorization decisions
• Referenced by regulatory agencies and hospital formulary committees
• Updated annually with the latest clinical evidence

If your research contributes evidence that informs the Standards of Care, publishing in Diabetes Care maximizes the chance that your findings reach the guideline authors directly. The editorial board and guideline committee overlap significantly. This isn't about gaming the system. It's about ensuring that evidence reaches the decision-makers who synthesize it into clinical practice.

• Page charges on subscription track: These vary by article type but can add $500-$1,500 to the cost of a subscription-track publication.
• Tax: State and local taxes may apply for US institutions. VAT for European institutions.
• Supplementary data: Clinical diabetes papers often include extensive supplementary tables (baseline characteristics, subgroup analyses, sensitivity analyses). Preparation is time-intensive.
• Statistical review: Diabetes Care may request additional statistical analyses or independent review during revision. Budget for biostatistics consulting if your institution charges for this service.
• Graphical abstract: Increasingly expected for clinical research articles. Professional preparation costs $200-$500.

Diabetes Care typically returns a first decision within 3-6 weeks. The full review-to-acceptance timeline runs 3-6 months for successful manuscripts. One or two rounds of revision are standard.

The journal uses a tiered review process. Statistical editors review the methodology of clinical studies, and clinical editors assess the practice relevance. This dual lens means your paper needs both methodological rigor and clinical applicability to succeed.

For diabetes researchers considering Diabetes Care:

1. Check institutional coverage. Ask your library about ADA publishing arrangements. Coverage is growing.
2. ADA member? Membership benefits may reduce page charges and provide other publishing advantages.
3. NIDDK/NIH-funded? The free green route (subscription + PMC deposit after 12 months) satisfies federal policy.
4. Choosing between Diabetes Care and Diabetologia? If you're at a European institution with Springer Nature R&P, Diabetologia may be cheaper in practice. If your paper has strong clinical implications for US practice, Diabetes Care has more direct influence on ADA guidelines.
5. Paper more basic than clinical? Consider Diabetes (the ADA's basic/translational journal) at a similar or lower APC.

Clinical diabetes papers need clear endpoints, well-defined patient populations, and conclusions that translate into actionable practice recommendations. Diabetes Care editors want to know: "How does this change how we treat patients?" Run a free readiness scan to ensure your manuscript answers that question clearly before you submit.

For the latest fee schedule and author guidelines, visit the Diabetes Care author information page.